217 related articles for article (PubMed ID: 15998962)
1. Molecular diagnosis of lymphoma: outcome prediction by gene expression profiling in diffuse large B-cell lymphoma.
Last K; Debarnardi S; Lister TA
Methods Mol Med; 2005; 115():15-63. PubMed ID: 15998962
[TBL] [Abstract][Full Text] [Related]
2. Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning.
Shipp MA; Ross KN; Tamayo P; Weng AP; Kutok JL; Aguiar RC; Gaasenbeek M; Angelo M; Reich M; Pinkus GS; Ray TS; Koval MA; Last KW; Norton A; Lister TA; Mesirov J; Neuberg DS; Lander ES; Aster JC; Golub TR
Nat Med; 2002 Jan; 8(1):68-74. PubMed ID: 11786909
[TBL] [Abstract][Full Text] [Related]
3. National Oncology Forum: perspectives for the year 2000.
DeVita VT; Bleickardt EW
Cancer J; 2001; 7 Suppl 1():S2-13. PubMed ID: 11504281
[TBL] [Abstract][Full Text] [Related]
4. A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma.
Wright G; Tan B; Rosenwald A; Hurt EH; Wiestner A; Staudt LM
Proc Natl Acad Sci U S A; 2003 Aug; 100(17):9991-6. PubMed ID: 12900505
[TBL] [Abstract][Full Text] [Related]
5. Microarray gene expression data with linked survival phenotypes: diffuse large-B-cell lymphoma revisited.
Segal MR
Biostatistics; 2006 Apr; 7(2):268-85. PubMed ID: 16284340
[TBL] [Abstract][Full Text] [Related]
6. The feasibility of gene expression profiling generated in fine-needle aspiration specimens from patients with follicular lymphoma and diffuse large B-cell lymphoma.
Goy A; Stewart J; Barkoh BA; Remache YK; Katz R; Sneige N; Gilles F
Cancer; 2006 Feb; 108(1):10-20. PubMed ID: 16329118
[TBL] [Abstract][Full Text] [Related]
7. [Analysis of genomic copy number alterations of malignant lymphomas and its application for diagnosis].
Tagawa H
Gan To Kagaku Ryoho; 2007 Jul; 34(7):975-82. PubMed ID: 17637530
[TBL] [Abstract][Full Text] [Related]
8. Prediction of clinical behaviour and treatment for cancers.
Futschik ME; Sullivan M; Reeve A; Kasabov N
Appl Bioinformatics; 2003; 2(3 Suppl):S53-8. PubMed ID: 15130817
[TBL] [Abstract][Full Text] [Related]
9. Recent advances in the molecular diagnosis of diffuse large B-cell lymphoma.
Fu K; Iqbal J; Chan WC
Expert Rev Mol Diagn; 2005 May; 5(3):397-408. PubMed ID: 15934816
[TBL] [Abstract][Full Text] [Related]
10. The microarray way to tailored cancer treatment.
Van 't Veer LJ; De Jong D
Nat Med; 2002 Jan; 8(1):13-4. PubMed ID: 11786894
[No Abstract] [Full Text] [Related]
11. Gene expression profiling and outcome prediction in non-Hodgkin lymphoma.
Dave S
Biol Blood Marrow Transplant; 2006 Jan; 12(1 Suppl 1):50-2. PubMed ID: 16399585
[TBL] [Abstract][Full Text] [Related]
12. Data pattern analysis for the individualised pretherapeutic identification of high-risk diffuse large B-cell lymphoma (DLBCL) patients by cytomics.
Valet GK; Hoeffkes HG
Cytometry A; 2004 Jun; 59(2):232-6. PubMed ID: 15170602
[TBL] [Abstract][Full Text] [Related]
13. Randomized maps for assessing the reliability of patients clusters in DNA microarray data analyses.
Bertoni A; Valentini G
Artif Intell Med; 2006 Jun; 37(2):85-109. PubMed ID: 16720093
[TBL] [Abstract][Full Text] [Related]
14. Forkhead box protein P1 expression in mucosa-associated lymphoid tissue lymphomas predicts poor prognosis and transformation to diffuse large B-cell lymphoma.
Sagaert X; de Paepe P; Libbrecht L; Vanhentenrijk V; Verhoef G; Thomas J; Wlodarska I; De Wolf-Peeters C
J Clin Oncol; 2006 Jun; 24(16):2490-7. PubMed ID: 16636337
[TBL] [Abstract][Full Text] [Related]
15. Clinical quantitation of diagnostic and predictive gene expression levels in follicular and diffuse large B-cell lymphoma by RT-PCR gene expression profiling.
Sakhinia E; Glennie C; Hoyland JA; Menasce LP; Brady G; Miller C; Radford JA; Byers RJ
Blood; 2007 May; 109(9):3922-8. PubMed ID: 17255358
[TBL] [Abstract][Full Text] [Related]
16. Profiling of apoptosis genes allows for clinical stratification of primary nodal diffuse large B-cell lymphomas.
Muris JJ; Ylstra B; Cillessen SA; Ossenkoppele GJ; Kluin-Nelemans JC; Eijk PP; Nota B; Tijssen M; de Boer WP; van de Wiel M; van den Ijssel PR; Jansen P; de Bruin PC; van Krieken JH; Meijer GA; Meijer CJ; Oudejans JJ
Br J Haematol; 2007 Jan; 136(1):38-47. PubMed ID: 17062006
[TBL] [Abstract][Full Text] [Related]
17. Prognostic biomarkers in diffuse large B-cell lymphoma.
Lossos IS; Morgensztern D
J Clin Oncol; 2006 Feb; 24(6):995-1007. PubMed ID: 16418498
[TBL] [Abstract][Full Text] [Related]
18. Diffuse large B-cell lymphoma with overexpression of cyclin e substantiates poor standard treatment response and inferior outcome.
Tzankov A; Gschwendtner A; Augustin F; Fiegl M; Obermann EC; Dirnhofer S; Went P
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2125-32. PubMed ID: 16609025
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic and prognostic significance of gene expression profiling in lymphomas.
Leich E; Hartmann EM; Burek C; Ott G; Rosenwald A
APMIS; 2007 Oct; 115(10):1135-46. PubMed ID: 18042147
[TBL] [Abstract][Full Text] [Related]
20. [Molecular diagnosis of malignant lymphomas].
Holte H; Kvaløy S; Delabie J; Trøen G; Smeland EB
Tidsskr Nor Laegeforen; 2009 Nov; 129(22):2352-6. PubMed ID: 19935935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
